Name | Number of supported studies | Average coverage | |
---|---|---|---|
hepatocyte | 5 studies | 66% ± 14% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
liver | 3 studies | 34% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 15230.46 | 226 / 226 | 97% | 223.52 | 394 / 406 |
pancreas | 96% | 321.63 | 314 / 328 | 80% | 14.04 | 142 / 178 |
stomach | 89% | 343.72 | 320 / 359 | 77% | 8.59 | 221 / 286 |
intestine | 67% | 158.20 | 652 / 966 | 87% | 10.65 | 459 / 527 |
lung | 98% | 140.14 | 564 / 578 | 42% | 6.60 | 480 / 1155 |
ovary | 97% | 1643.72 | 174 / 180 | 2% | 0.12 | 9 / 430 |
bladder | 67% | 22.90 | 14 / 21 | 31% | 3.39 | 155 / 504 |
breast | 70% | 76.40 | 322 / 459 | 12% | 0.97 | 132 / 1118 |
adipose | 74% | 65.33 | 891 / 1204 | 0% | 0 | 0 / 0 |
esophagus | 23% | 11.03 | 327 / 1445 | 45% | 11.33 | 83 / 183 |
kidney | 61% | 19.08 | 54 / 89 | 7% | 0.52 | 62 / 901 |
spleen | 59% | 30.35 | 141 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 33% | 17.60 | 439 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 32% | 41.69 | 299 / 929 | 0% | 0 | 0 / 0 |
adrenal gland | 26% | 7.51 | 66 / 258 | 4% | 0.21 | 10 / 230 |
uterus | 11% | 7.15 | 19 / 170 | 15% | 6.48 | 70 / 459 |
skin | 23% | 7.57 | 412 / 1809 | 0% | 0.01 | 2 / 472 |
muscle | 10% | 2.81 | 84 / 803 | 0% | 0 | 0 / 0 |
prostate | 7% | 2.25 | 17 / 245 | 0% | 0 | 0 / 502 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.19 | 2 / 29 |
heart | 7% | 2.15 | 56 / 861 | 0% | 0 | 0 / 0 |
thymus | 4% | 1.05 | 23 / 653 | 1% | 0.04 | 6 / 605 |
brain | 1% | 0.38 | 14 / 2642 | 0% | 0.01 | 2 / 705 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0045732 | Biological process | positive regulation of protein catabolic process |
GO_0006958 | Biological process | complement activation, classical pathway |
GO_1903027 | Biological process | regulation of opsonization |
GO_0007596 | Biological process | blood coagulation |
GO_0045959 | Biological process | negative regulation of complement activation, classical pathway |
GO_0045087 | Biological process | innate immune response |
GO_0009609 | Biological process | response to symbiotic bacterium |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0005515 | Molecular function | protein binding |
Gene name | C4BPB |
Protein name | C4b-binding protein beta chain Complement component 4 binding protein beta |
Synonyms | |
Description | FUNCTION: Controls the classical pathway of complement activation. It binds as a cofactor to C3b/C4b inactivator (C3bINA), which then hydrolyzes the complement fragment C4b. It also accelerates the degradation of the C4bC2a complex (C3 convertase) by dissociating the complement fragment C2a. It also interacts with anticoagulant protein S and with serum amyloid P component. The beta chain binds protein S. |
Accessions | ENST00000391923.1 [P20851-1] ENST00000367078.8 [P20851-1] P20851 ENST00000243611.9 [P20851-1] ENST00000452902.6 Q5VVQ7 ENST00000367076.7 [P20851-2] |